| RNAZ Average Annual Return Chart Since 2021 | |||
Also see: • RNAZ stock yearly return 2022 • RNAZ stock yearly return 2023 • RNAZ stock yearly return 2024 • RNAZ YTD return | |||
| Average Annual Return Benchmarks |
|
Compare RNAZ average annual return versus benchmarks: S&P Average Annual Return Dow Average Annual Return Nasdaq 100 Average Annual Return Russell 2000 Average Annual Return Gold Average Annual Return 10 Year Treasury Average Annual Return |
| RNAZ Share Performance |
| RNAZ Average Annual Return Table Since 2021 | ||||||||||||||||||||||||||||||
RNAZ average annual return is presented with the assumption of reinvestments of any dividends on ex-date. |
| About TransCode Therapeutics Inc |
| TransCode Therapeutics, Inc. is a clinical-stage oncology company focusing on metastatic disease treatment through RNA therapeutics using their TTX nanoparticle platform. Their lead candidate, TTX-MC138, targets metastatic tumors overexpressing microRNA-10b, a key biomarker. Their preclinical projects include TTX-siPDL1, which modulates PD-L1, TTX-RIGA, an RNA-based RIG-I agonist enhancing innate immunity in tumors, and TTX-CRISPR, a CRISPR/Cas9 therapy for correcting cancer genes. Additionally, they have TTX-mRNA, a platform for creating cancer vaccines specific to tumor types. The RNAZ average annual return since 2021 is shown above.
The Average Annual Return on the RNAZ average annual return since 2021 page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends. Thus, researching Average Annual Returns is good practice for investors — whether RNAZ average annual return since 2021 or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the RNAZ average annual return calculation with any dividends reinvested as applicable (on ex-dates). |
| RNAZ Current Stock Quote |
 Free RNAZ Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Don't Forget Dividends in Average Annual Return! | |
|
| Average Annual Return Peers |
| TransCode Therapeutics (RNAZ) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:
RNXT Average Annual Return |
Video: Don't Forget Dividends in Average Annual Return!